These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4550720)

  • 21. The role of embolization and nephrectomy in the treatment of metastatic renal carcinoma.
    Swanson DA; Wallace S; Johnson DE
    Urol Clin North Am; 1980 Oct; 7(3):719-30. PubMed ID: 7456183
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma carcinoembryonic antigen in renal cell carcinoma patients.
    Chu TM; Shukla SK; Mittleman AO; Murphy GP
    J Urol; 1974 Jun; 111(6):742-4. PubMed ID: 4830874
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal cell carcinoma: tumor membrane lymphocyte stimulation assay.
    Hemstreet GP
    Natl Cancer Inst Monogr; 1978 Dec; (49):165-8. PubMed ID: 748768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fate of a kidney-specific mesonephric antigen during the differentiation of the epididymis.
    Linder E
    Ann N Y Acad Sci; 1971 Jun; 177():204-13. PubMed ID: 4110289
    [No Abstract]   [Full Text] [Related]  

  • 25. Specificity of cellular immunity to renal cell carcinoma.
    Daly JJ; Prout GR; Ahl CA; Lin JC
    J Urol; 1974 Apr; 111(4):448-52. PubMed ID: 4819368
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunochemical study of the alpha-globulins in human kidney tumor tissue].
    Pchelkina ZM; Matveev BP; Rykunov EI; Terent'ev AA; Tatarinov IuS
    Vopr Med Khim; 1979; 25(4):439-41. PubMed ID: 89757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The detection and clinical significance of antibodies to tumor-associated antigens in patients with renal cell carcinoma.
    Dekernion JB; Ramming KP; Gupta RK
    J Urol; 1979 Sep; 122(3):300-5. PubMed ID: 469998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal adenocarcinoma treated with regressor plasma].
    Hippe E; Hvidt V; Jensen A; Lauridsen L
    Ugeskr Laeger; 1976 Jul; 138(28):1689-92. PubMed ID: 936322
    [No Abstract]   [Full Text] [Related]  

  • 29. [Isolation of tumour localizing antibodies by immunosorbents. 3. Isolation of heterologous antibodies against human portio carcinoma and hypernephroma (author's transl)].
    Teichmann B; Vogt R
    Arch Geschwulstforsch; 1974; 43(2):145-56. PubMed ID: 4849017
    [No Abstract]   [Full Text] [Related]  

  • 30. Regression of metastatic renal cell carcinoma following nephrectomy.
    Garfield DH; Kennedy BJ
    Cancer; 1972 Jul; 30(1):190-6. PubMed ID: 5040742
    [No Abstract]   [Full Text] [Related]  

  • 31. Smooth muscle autoantibodies in normal rabbit sera. Cross-reaction with human platelets as demonstrated by immunofluorescence.
    Betterle C; Fabris F; del Prete GF; Bersani G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(4):561-8. PubMed ID: 72713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auto-antibodies in malignant disease.
    Whitehouse JM; Fairley G
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):197-202. PubMed ID: 4589246
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.
    Montie JE; Straffon RA; Deodhar SD; Barna B
    J Urol; 1976 Mar; 115(3):239-42. PubMed ID: 1255882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of adjuvant therapy for renal cell cancer.
    Sagalowsky A; Donohue J
    J Indiana State Med Assoc; 1979 Jul; 72(7):521-4. PubMed ID: 383849
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytotoxic serum factors in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1974 Mar; 111(3):330-3. PubMed ID: 4813571
    [No Abstract]   [Full Text] [Related]  

  • 36. Vagaries of renal cell carcinoma.
    Wagle DG
    J Med; 1972; 3(3):178-89. PubMed ID: 4508257
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA; Dekernion JB; Ramming KP
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
    Ackermann R
    Eur Urol; 1975; 1(3):154-6. PubMed ID: 786650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypernephroma and amyloidosis.
    Knight A; Aronoff A
    Can Med Assoc J; 1966 Dec; 95(26):1379-84. PubMed ID: 4288914
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic evidence suggesting a viral etiology of human osteosarcoma.
    Reilly CA; Pritchard DJ; Biskis BO; Finkel MP
    Cancer; 1972 Sep; 30(3):603-9. PubMed ID: 4116424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.